Attributes | Values |
---|
rdf:type
| |
description
| - wetenschappelijk artikel (nl)
- наукова стаття, опублікована у квітні 1991 (uk)
- article scientifique publié en 1991 (fr)
- im April 1991 veröffentlichter wissenschaftlicher Artikel (de)
- artículu científicu espublizáu n'abril de 1991 (ast)
- scientific article published on 01 April 1991 (en)
|
publication date
| |
publication date
| |
language of work or name
| |
language of work or name
| |
author name string
| |
author name string
| - R Roberts
- D S Baim
- J M Gore
- E R Passamani
- J H Chesebro
- E Braunwald
- W J Rogers
- D O Williams
- J D Babb
- M Frederick
|
rdfs:label
| - Selective versus routine predischarge coronary arteriography after therapy with recombinant tissue-type plasminogen activator, heparin and aspirin for acute myocardial infarction. TIMI II Investigators (en)
- Selective versus routine predischarge coronary arteriography after therapy with recombinant tissue-type plasminogen activator, heparin and aspirin for acute myocardial infarction. TIMI II Investigators (nl)
|
skos:prefLabel
| - Selective versus routine predischarge coronary arteriography after therapy with recombinant tissue-type plasminogen activator, heparin and aspirin for acute myocardial infarction. TIMI II Investigators (en)
- Selective versus routine predischarge coronary arteriography after therapy with recombinant tissue-type plasminogen activator, heparin and aspirin for acute myocardial infarction. TIMI II Investigators (nl)
|
name
| - Selective versus routine predischarge coronary arteriography after therapy with recombinant tissue-type plasminogen activator, heparin and aspirin for acute myocardial infarction. TIMI II Investigators (en)
- Selective versus routine predischarge coronary arteriography after therapy with recombinant tissue-type plasminogen activator, heparin and aspirin for acute myocardial infarction. TIMI II Investigators (nl)
|
title
| |
title
| - Selective versus routine predischarge coronary arteriography after therapy with recombinant tissue-type plasminogen activator, heparin and aspirin for acute myocardial infarction. TIMI II Investigators (en)
|
page(s)
| |
page(s)
| |
instance of
| |
instance of
| |
main subject
| |
main subject
| |
PubMed ID
| |
PubMed ID
| |
PubMed ID
| |
published in
| |
published in
| |
issue
| |
volume
| |
issue
| |
volume
| |
DOI
| |
DOI
| |
DOI
| - 10.1016/0735-1097(91)90823-R
|
is about
of | |
is cites work
of | |
is cites work
of | |